HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ineffective control of murine cytomegalovirus by IE1-specific cytotoxic T lymphocytes during protracted infection in the lung.

Abstract
Interstitial pneumonia caused by cytomegalovirus (CMV) is a fatal disease in immunocompromised patients. In order to examine the defense mechanism against the virus in the lung, we employed an intratracheal infection model in susceptible mice. In mice infected intratracheally with murine CMV, a protracted infection was observed where infectious virus was detected up to 21 days of infection. During this prolonged infection, massive accumulation in the lung of CD8+ T cells with activated phenotypes occurred and these CD8+ T cells showed direct ex vivo cytolytic activity against target cells pulsed with the nonamer peptide derived from IE1 protein of the virus, which has been shown to be the dominant epitope recognized by most of virus-specific CTL. Moreover, adoptive transfer of in vitro induced IE1 peptide-specific CTL line showed no anti-virus effect in the lung, although they were effective in the spleen. Hence, there is reason to assume the IE1-specific CTL induced in vivo or in vitro plays limited roles during the prolonged infection in the lung.
AuthorsQ J Chen, H Yoshida, H Takimoto, T Ninomiya, M Ohtsu, G Kimura, K Nomoto
JournalArchives of virology (Arch Virol) Vol. 145 Issue 7 Pg. 1291-304 ( 2000) ISSN: 0304-8608 [Print] Austria
PMID10963338 (Publication Type: Journal Article)
Chemical References
  • Antigens, Viral
  • IE1 protein, cytomegalovirus
  • Immediate-Early Proteins
  • Viral Proteins
Topics
  • Animals
  • Antigen Presentation
  • Antigens, Viral (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cytomegalovirus (immunology)
  • Cytomegalovirus Infections (immunology)
  • Cytotoxicity, Immunologic
  • Female
  • Immediate-Early Proteins (immunology)
  • Lung Diseases (immunology, virology)
  • Mice
  • Mice, Inbred BALB C
  • Viral Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: